Global Hormonal Contraceptive Market: Analysis & Evolving Opportunities Studied for the Period until 2026 || Key Players - ALLERGAN, Afaxys Inc., Bayer AG, Agile Therapeutics Inc., Merck & Co. Inc., Pfizer Inc., HLL Lifecare Limited, and Piramal Enterpris

A fresh report has been added to the wide database of Market Research Report Search Engine (MRRSE). The research study is titled “Global Hormonal Contraceptive Market: Analysis & Evolving Opportunities Studied for the Period Until 2026” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview.

The research is a combination of primary and secondary research. The primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved the study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2018 to 2026, considering the macro and microenvironmental factors. Growth rates for each segment in the global hormonal contraceptives market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

To Get Sample Copy of Report, Click here @ https://www.mrrse.com/sample/17463

A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. This section of the report also includes the market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global hormonal contraceptives market.

Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. Market size estimations involved in-depth study of features of different types of product types. Additionally, market related factors such as raise in prevalence PCOS, product launch, and historical year-on-year growth have been taken into consideration while estimating the market size.

Contraceptives can be defined as a drug or device that can prevent pregnancy. Contraceptives can be of various types such as hormonal and non-hormonal. Hormonal contraceptives are a type of contraceptives that act on the endocrine system for birth control. Demand for hormonal contraceptives market is rising owing to the increase in prevalence of women’s health-related problems such as PCOS and delayed child bearing.

Based on method, the global hormonal contraceptives market has been classified into oral contraceptives, transdermal patches, injectable contraceptives, intrauterine contraceptives, and vaginal rings. The oral contraceptives segment is expected to hold a significant share of the global market during the forecast period.

In terms of hormones, the global hormonal contraceptives market has been segregated into progestin only and combined hormones. The combined hormones segment is anticipated to dominate the market from 2018 to 2026.

Based on distribution channel, the global hormonal contraceptives market has been segmented into drug stores, gynecology/ fertility clinics, E-commerce, and others. The drug stores segment held a prominent share of the global market, in terms of revenue, in 2017.

In terms of geography, the global hormonal contraceptives market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries.

Browse Complete Report with TOC @ https://www.mrrse.com/hormonal-contraceptives-market

The report also profiles major players in the global hormonal contraceptives market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include ALLERGAN, Afaxys, Inc., Bayer AG, Agile Therapeutics, Inc., Merck & Co., Inc., Pfizer Inc., HLL Lifecare Limited, and Piramal Enterprises.

The global hormonal contraceptives market has been segmented as follows:

Global Hormonal Contraceptives Market, by Method

Oral Contraceptives

Transdermal Patches

Injectable Contraceptives

Intrauterine Contraceptives

Vaginal Rings

Global Hormonal Contraceptives Market, by Hormones

Progestin Only

Combined Hormones

Global Hormonal Contraceptives Market, by Distribution Channel

Drug Stores

Gynecology/ Fertility Clinics

E-commerce

Others

Global Hormonal Contraceptives Market, by Region

North America

U.S.

Canada

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Israel

Rest of Middle East & Africa

Enquire about this Report @ https://www.mrrse.com/enquiry/17463

About Market Research Reports Search Engine (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/

This release was published on openPR.